Treatment Guided by Comprehensive Genomic Profiling and Expert MTB Decision-Making Improves Outcomes in Pretreated Patients with Metastatic Cancer By Ogkologos - October 14, 2025 51 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ROME study Source RELATED ARTICLESMORE FROM AUTHOR Rucaparib Monotherapy Provides Significant and Durable Long-Term Benefit as First-Line Maintenance for Patients with Advanced Ovarian Cancer with and without HRD FDA Approves Belantamab Mafodotin-blmf for Relapsed or Refractory Multiple Myeloma Long-Term Follow-Up Data Support Longer RFS with Adjuvant Nivolumab Than with Ipilimumab in Patients with Melanoma at High Risk for Recurrence MOST POPULAR FDA Approves Cosibelimab-ipdl for Metastatic or Locally Advanced Cutaneous Squamous Cell... January 31, 2025 EMA Recommends Granting a Marketing Authorisation for Vorasidenib August 13, 2025 The Growths On This Woman’s Lips Are A Sign That She... April 17, 2020 Altering Diet Enhances Response to Cancer Treatments in Mice September 3, 2019 Load more HOT NEWS Expecting Mom Finds Pregnant Stray Cat And Gives Her A Home Drug Regimen Boosts Survival of People with Advanced Colorectal Cancer How My Navy Career Helped Shape My Positive Attitude During My... Army Veteran Gets Life-Saving Heart Transplant: ‘It’s A True Miracle’
